Drugs that block PI3K and downstream targets, such as pan-PI3K inhibitors, isoform-specific PI3K inhibitors, AKT inhibitors, and mTOR inhibitors, have been discovered by the role of the PI3K pathway in the growth and progression of PCa. The gene discussed is MTOR; the disease is posterior cortical atrophy.